OmniAb (OABI) Non-Current Assets (2021 - 2026)

OmniAb (OABI) reported Non-Current Assets of $228.5 million for Q1 2026, down 9.53% year-over-year from $252.6 million in Q1 2025, and down 2.99% quarter-over-quarter from $235.6 million in Q4 2025.

OmniAb (OABI) Non-Current Assets (2021 - 2026) Analysis & Trends

OmniAb (OABI) has 6 years of Non-Current Assets data on file, last reported at $228.5 million in Q1 2026.

  • Non-Current Assets for Q1 2026 came in at $228.5 million, down 9.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $955.5 million (down 8.56% YoY), and the FY2025 annual result was $235.6 million, down 8.49% from the prior year.
  • Non-Current Assets slipped to $228.5 million in Q1 2026 per OABI's latest filing, from $235.6 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $296.3 million in Q4 2022 and troughed at $228.5 million in Q1 2026.
  • A 5-year average of $260.5 million and a median of $257.4 million in 2024 frame the typical range for Non-Current Assets.
  • The sharpest annual moves came in 2023 and 2026: Non-Current Assets grew 23.82% in 2023, then dropped 9.53% in 2026.
  • A 5-year view of Non-Current Assets shows it stood at $296.3 million in 2022, then decreased by 5.38% to $280.3 million in 2023, then slipped by 8.17% to $257.4 million in 2024, then dropped by 8.49% to $235.6 million in 2025, then decreased by 2.99% to $228.5 million in 2026.
  • Business Quant data shows OABI's Non-Current Assets at $228.5 million in Q1 2026, $235.6 million in Q4 2025, and $243.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 62,953.78
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4.56 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 486.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 30.30 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - 39.71 Mn
10 OmniAb 294.96 Mn 252.00 Mn 14.41 Mn 228.53 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 228.53 Mn
Dec 31, 2025 235.57 Mn
Sep 30, 2025 243.34 Mn
Jun 30, 2025 248.06 Mn
Mar 31, 2025 252.60 Mn
Dec 31, 2024 257.42 Mn
Sep 30, 2024 264.95 Mn
Jun 30, 2024 269.96 Mn
Mar 31, 2024 275.84 Mn
Dec 31, 2023 280.32 Mn
Sep 30, 2023 284.86 Mn
Jun 30, 2023 289.30 Mn
Mar 31, 2023 291.96 Mn
Dec 31, 2022 296.26 Mn
Sep 30, 2022 237.19 Mn
Jun 30, 2022 236.10 Mn
Mar 31, 2022 235.80 Mn
Dec 31, 2021 281.92 Mn
Sep 30, 2021 235.75 Mn